Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. - Wikidata - wikimedia - TriplyDB

Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.

Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q44610222

about

The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.Activating KIR/HLA complexes in classic Kaposi's Sarcoma GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases HLA associations with nasopharyngeal carcinoma.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.The Yin and Yang of HLA and KIR in human disease Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study KIR and disease: a model system or system of models?Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation.KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.

P2860

Q26742135-67910B09-4278-45F5-83F2-4D4F4925A4AE Q31037177-18E3CD59-0258-4FB8-B037-5943E6361D8B Q33283515-0D2500DE-3990-4A68-A934-8CB84B61D2AE Q34307792-788CA3DB-B91B-42C7-8A0B-AA3E6402C62F Q34756777-1FA03338-9C74-4C7B-9055-BD9A7D6038EC Q35812949-7C1EC5A1-FBBA-44F2-84F1-330B5D3C7E93 Q36048703-ADCC639E-D6EE-42C2-80C9-039CD962C29C Q36053844-E4FE991F-8991-4A05-96A6-944026E3C1EC Q36125265-72687643-2C4B-44D6-A509-13230197AF6D Q36407362-5136A853-45F7-4E5B-A2C4-B5DB6FD31C6B Q36410540-76C41E76-41D5-4CC6-9081-1FAC349D6FDE Q36471507-C490EAA1-AEC4-4BB0-9946-A86B0B2EABB5 Q36481429-85318548-1DB0-48B4-98EB-F0ADBB7D8F41 Q36652201-942DCDB6-532D-45AA-BCE5-46ED65B00D68 Q36830203-44F9EEF1-9259-43F4-AB15-D2D1F77A0DEC Q37171499-FF3BBCD7-6797-497A-983B-08DA9CFDCF98 Q37696089-E2D011B3-7D72-4863-805D-DF81924F0501 Q38264787-BD830B34-8150-4743-9F0C-C15A2F2BE22F Q39036828-EEE25ECF-9D1A-4182-813D-463A79CC9A5B Q40777800-32B523DF-6C85-4AFE-9B77-CFB45ADFF92B Q47102950-72E925DC-DFC1-4F38-9187-4D6B18FEF024

P2860

Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q44610222

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@en

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@nl

type

label

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@en

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@nl

prefLabel

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@en

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@nl

P1433

Q44610222-F93140EF-344F-41AC-8034-3F0F5AD37447

P1476

Q44610222-96D9BFBE-A2E9-4555-8409-0F3EDD46EA7C

P2093

Q44610222-68053AE6-7EFE-47D6-B6F8-3B9FD9034289

Q44610222-7822A21A-E0BC-448F-BC10-611C556D1AA6

Q44610222-7BA9A882-7ED1-42B4-ADEE-609CDF6FE7EA

Q44610222-85835F8E-32C8-4E3C-BBDF-5DCAA1EA01C6

Q44610222-86B74A20-F66E-4351-BEF6-E9A25CC44317

Q44610222-9B62CD49-4761-4739-AAC2-1CC1F06CD8A0

Q44610222-A9EAAACD-07B2-4EE2-85AB-047F4B0A6837

Q44610222-AA5D616D-44CF-4CE9-9BEC-A6C6594C356E

Q44610222-B1B06964-2305-4212-A33B-392FED38B90D

Q44610222-DFA130AF-BB5A-4DCA-A5C6-BC19B65CCE20

P304

Q44610222-3680C379-74E5-4B2B-91F7-FB24393B1346

P31

Q44610222-B730933E-CE59-4CDD-883E-9ABC7D93D3A6

P356

Q44610222-4CF502AE-1960-4C2C-8DEE-852EBBE84EDA

P433

Q44610222-001F6ADD-EE2A-4306-90E4-21434AE3CADC

P478

Q44610222-BAC6845A-7CF1-4B8E-9944-3C849000C0AD

P577

Q44610222-1BD24C65-E784-4861-B502-9E1317DDCF9B

P698

Q44610222-E8FA50EA-8014-4289-A736-C2F60A1AD4C6

P356

1055-9965.EPI-05-0229

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Variation of the killer cell i ...... s in nasopharyngeal carcinoma.

@en

P2093

Allan Hildesheim

http://www.w3.org/2001/XMLSchema#string

Chien-Jen Chen

http://www.w3.org/2001/XMLSchema#string

Jen-Yang Chen

http://www.w3.org/2001/XMLSchema#string

Mary Carrington

http://www.w3.org/2001/XMLSchema#string

Maureen Martin

http://www.w3.org/2001/XMLSchema#string

Melinda Butsch Kovacic

http://www.w3.org/2001/XMLSchema#string

Raymond Apple

http://www.w3.org/2001/XMLSchema#string

Tatyana Fuksenko

http://www.w3.org/2001/XMLSchema#string

Xiaojiang Gao

http://www.w3.org/2001/XMLSchema#string

Yu-Juen Cheng

http://www.w3.org/2001/XMLSchema#string

P304

2673-2677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-05-0229

http://www.w3.org/2001/XMLSchema#string

P433

11 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16284396

http://www.w3.org/2001/XMLSchema#string